109 related articles for article (PubMed ID: 7617069)
1. Cathepsin B in predicting the extent of the cervix carcinoma.
Makarewicz R; Drewa G; Szymanski W; Skonieczna-Makarewicz I
Neoplasma; 1995; 42(1):21-4. PubMed ID: 7617069
[TBL] [Abstract][Full Text] [Related]
2. A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma.
Makarewicz R; Drewa G
Acta Biochim Pol; 1996; 43(3):521-4. PubMed ID: 8922036
[TBL] [Abstract][Full Text] [Related]
3. [Activity of cathepsin B and D in blood serum of women with uterine cervix neoplasms].
Makarewicz R; Drewa G; Szymański W
Ginekol Pol; 1994 Oct; 65(10):578-81. PubMed ID: 7729719
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B and antiproteases in patients with carcinoma of the cervix.
Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G; de la Huerta-Sánchez R; Alfaro-Aceves L
Arch Invest Med (Mex); 1981; 12(4):517-37. PubMed ID: 7332393
[No Abstract] [Full Text] [Related]
5. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
6. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
7. [Protease-antiprotease balance in patients with invasive carcinoma of the cervix and uterus before and after radiotherapy].
Benítez-Bribiesca L; de la Huerta-Sánchez R; Villanueva C; Freyre Horta R; Pastrana L; Guevara R
Arch Invest Med (Mex); 1989; 20(1):9-21. PubMed ID: 2788398
[TBL] [Abstract][Full Text] [Related]
8. Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
Santos-Filho AS; Triginelli SA; Traiman P; Cunha-Melo JR; Silva-Filho AL
Arch Gynecol Obstet; 2007 Jan; 275(1):13-7. PubMed ID: 16858573
[TBL] [Abstract][Full Text] [Related]
9. Proteinase activity in invasive cancer of the breast. Correlation with tumor progression.
Benítez-Bribiesca L; Martínez G; Ruíz MT; Gutiérrez-Delgado F; Utrera D
Arch Med Res; 1995; 26 Spec No():S163-8. PubMed ID: 8845643
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Devetzi M; Scorilas A; Tsiambas E; Sameni M; Fotiou S; Sloane BF; Talieri M
Gynecol Oncol; 2009 Mar; 112(3):531-6. PubMed ID: 19110306
[TBL] [Abstract][Full Text] [Related]
11. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72-kDa metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Romanini C; Biagini G
Gynecol Oncol; 1996 Apr; 61(1):83-9. PubMed ID: 8626123
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
14. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Nagai N; Oshita T; Murakami J; Ohama K
Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
[TBL] [Abstract][Full Text] [Related]
16. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
17. Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy.
Bradamante V; Smigovec E; Buković D; Geber J; Matanić D
Coll Antropol; 2000 Dec; 24(2):373-80. PubMed ID: 11216405
[TBL] [Abstract][Full Text] [Related]
18. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
19. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
